Graphene oxide (GO) has attracted enormous interests due to its extraordinary properties. Recent studies have confirmed the cytotoxicity of GO, we further investigate its mutagenic potential in this study. The results showed that GO interfered with DNA replication and induced mutagenesis at molecular level. GO treatments at concentrations of 10 and 100 mg/mL altered gene expression patterns at cellular level, and 101 differentially expressed genes mediated DNA-damage control, cell apoptosis, cell cycle, and metabolism. Intravenous injection of GO at 4 mg/kg for 5 consecutive days clearly induced formation of micronucleated polychromic erythrocytes in mice, and its mutagenesis potential appeared to be comparable to cyclophosphamide, a classic mutagen. In conclusion, GO can induce mutagenesis both in vitro and in vivo, thus extra consideration is required for its biomedical applications. G raphene, firstly isolated from graphite in 2004 1 , is a flat monolayer of carbon atoms tightly packed into a two-dimensional (2D) honeycomb lattice. Due to the unique physicochemical properties, high surface area, excellent thermal conductivity, electric conductivity, and strong mechanical strength, graphene and graphene oxide (GO) have shown great promise in many applications, such as electronics, energy storage and conversion, mechanics, and biotechnologies [2][3][4][5][6] . Recently, many studies reported that GO has outstanding potentials in the field of biomedicine. GO and PEGylated GO exhibit certain advantages in vitro and in vivo drug delivery, such as high drug loading efficiency, controlled drug release, tumor-targeting drug delivery, and reversal effect against cancer drug resistance [7][8][9][10] . In addition, GO has strong optical absorbance in the near-infrared (NIR) region, thus is suitable for the photothermal therapy [11][12][13] . Now, it is possible to manufacture high-quality GO in large scale quantities 14,15 , and its industry production is increasing exponentially. Together with its potential applications in the biomedical field, the biosafety of GO is of critical importance. Many investigations have paid attentions to its biocompatibilty [16][17][18][19] . At a concentration approximate to 50 mg/mL or higher, GO begins to show the toxicity against erythrocytes, fibroblasts, and PC12 cells. It can induce cell apoptosis, hemolysis, and oxidative stress 16,18,19 . Surface chemical modification, such as PEGylation, is likely to improve the biocompatibility of GO 20,21 . However, the chemical bonds linking GO with modified polymer can be broken down in vivo, thus surface-modified GO can also induce in vivo toxicity.Several investigations have reported that treatments with carbon nanomaterials, such as nanodiamonds and multiwalled carbon nanotubes, can elevate the expression of p53, MOGG-1, and Rad51, which reflect the chromosomal DNA damage 22,23 . However, it is not clear whether this DNA damage induced by carbon nanomaterials can cause mutagenesis. GO, due to its unique nanosheet structure, can interact wi...
In this work, a novel soft-hard template method towards the direct fabrication of graphene films on silicon/silica substrate is developed via a tri-constituent self-assembly route. Using cetyl trimethyl ammonium bromide (CTAB) as a soft template, silica (SiO2) from tetramethoxysilane as a hard template, and pyrene as a carbon source, the self-assembly process allows the formation of a sandwich-like SiO2/CTAB/pyrene composite, which can be further converted to high quantity graphene films with a thickness of ~1 nm and a size of over 5 μm by thermal treatment. The morphology and thickness of the graphene films can be effectively controlled through the adjustment of the ratio of pyrene to CTAB. Furthermore, a high nonlinear refractive index n2 of ~10−12 m2 W−1 is measured from graphene/silica hybrid film, which is six orders of magnitude larger than that of silicon and comparable to the graphene from chemical vapor deposition process.
This study evaluates the reversal effects of graphene oxide (GO) used as a carrier for adriamycin (ADR) in cancer drug resistance, and provides a preliminary investigation into the reversal mechanism. ADR was loaded onto the GO surface (ADR-GO) by physical mixing and drug loading content was found to be high, up to 93.6%. In vitro releases of ADR from ADR-GO were studied using a dialysis method, and they exhibited a significant pH-sensitive property. Cell experiments showed that GO significantly enhanced the accumulation of ADR in MCF-7/ADR cells (an ADR resistant breast cancer cell line) and exhibited much higher cytotoxicity than free ADR, suggesting that ADR-GO could effectively reverse ADR resistance of MCF-7/ADR, with the reversal index reaching 8.35. Microscopy studies found that GO could effectively carry drug molecules into cells in both endocytosis-dependent and independent manners. In conclusion, use of GO as a carrier for chemotherapeutic agents is favorable for the treatment of drug resistant cancers.
Ultrafast time-resolved photoluminescence spectroscopy following one-and two-photon excitations of ZnO powder is used to gain unprecedented insight into the surprisingly high external quantum efficiency of its "green" defect emission band. The role of exciton diffusion, the effects of reabsorption, and the spatial distributions of radiative and nonradiative traps are comparatively elucidated for the ultraviolet excitonic and "green" defect emission bands in both unannealed nanometer-sized ZnO powders and annealed micrometersized ZnO:Zn powders. We find that the primary mechanism limiting quantum efficiency is surface recombination because of the high density of nonradiative surface traps in these powders. It is found that unannealed ZnO has a high density of bulk nonradiative traps as well, but the annealing process reduces the density of these bulk traps while simultaneously creating a high density of green-emitting defects near the particle surface. The data are discussed in the context of a simple rate equation model that accounts for the quantum efficiencies of both emission bands. The results indicate how defect engineering could improve the efficiency of ultraviolet-excited ZnO:Zn-based white light phosphors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.